Literature DB >> 24750712

Long-term treatment outcomes after intravascular ultrasound evaluation and stent placement for atherosclerotic subclavian artery obstructive lesions.

Takeshi Wada1, Katsutoshi Takayama2, Toshiaki Taoka3, Hiroyuki Nakagawa3, Kaoru Myouchin2, Toshiteru Miyasaka3, Toshiaki Akashi3, Masahiko Sakamoto3, Kimihiko Kichikawa3.   

Abstract

The objective of this study was to determine long-term outcomes after stent placement for subclavian artery (SA) obstructive lesions assisted by intraoperative intravascular ultrasound (IVUS). The study included 25 lesions in 24 patients who underwent stent placement assisted by intraoperative IVUS for subclavian artery stenosis or obstruction at our hospital between January 2003 and August 2010. Outcome was evaluated based on the results within 30 postoperative days (technical success rate, improvement in upper extremity ischemia, steal syndrome, left-right blood pressure difference, and perioperative complications) and the results after 30 postoperative days (incidence of vertebrobasilar artery territory infarction and restenosis). Stent placement and vessel dilatation were successful in all patients, without perioperative complications. Upper extremity ischemia, steal syndrome, and left-right blood pressure difference disappeared in all cases. During follow-up observation (6-96 months; median 51 months), no restenosis occurred at the stent placement site in any patient. In one case, four years after initial treatment, stenosis was noted proximal to the stent placement site. Satisfactory long-term as well as short-term outcomes were achieved after stent placement for SA obstructive lesions assisted by intraoperative IVUS evaluation.

Entities:  

Keywords:  atherosclerotic subclavian artery obstructive lesions; intravascular ultrasound; stent placement

Mesh:

Year:  2014        PMID: 24750712      PMCID: PMC4202855          DOI: 10.15274/NRJ-2014-10023

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  13 in total

1.  Endovascular treatment of the subclavian artery: stent implantation with or without predilatation.

Authors:  Max Amor; Guering Eid-Lidt; Zukai Chati; James R Wilentz
Journal:  Catheter Cardiovasc Interv       Date:  2004-11       Impact factor: 2.692

Review 2.  2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery.

Authors:  Thomas G Brott; Jonathan L Halperin; Suhny Abbara; J Michael Bacharach; John D Barr; Ruth L Bush; Christopher U Cates; Mark A Creager; Susan B Fowler; Gary Friday; Vicki S Hertzberg; E Bruce McIff; Wesley S Moore; Peter D Panagos; Thomas S Riles; Robert H Rosenwasser; Allen J Taylor
Journal:  J Am Coll Cardiol       Date:  2011-02-01       Impact factor: 24.094

3.  Long-term results of endovascular therapy for proximal subclavian arterial obstructive lesions.

Authors:  Ke-qin Wang; Zhong-gao Wang; Bao-zhong Yang; Chao Yuan; Wang-de Zhang; Biao Yuan; Tong Xing; Sheng-han Song; Tan Li; Chuan-jun Liao; Yang Zhang
Journal:  Chin Med J (Engl)       Date:  2010-01-05       Impact factor: 2.628

4.  Durability of percutaneous transluminal angioplasty for obstructive lesions of proximal subclavian artery: long-term results.

Authors:  Jean-Paul P M De Vries; L Cara Jager; Jos C Van den Berg; Tim Th C Overtoom; Rob G A Ackerstaff; Eric D W M Van de Pavoordt; Frans L Moll
Journal:  J Vasc Surg       Date:  2005-01       Impact factor: 4.268

5.  Carotid-subclavian bypass--a decade of experience.

Authors:  B A Perler; G M Williams
Journal:  J Vasc Surg       Date:  1990-12       Impact factor: 4.268

6.  Primary stenting of subclavian and innominate artery occlusive disease: a single center's experience.

Authors:  E N Brountzos; B Petersen; C Binkert; I Panagiotou; J A Kaufman
Journal:  Cardiovasc Intervent Radiol       Date:  2004-10-06       Impact factor: 2.740

7.  Subclavian revascularization. A quarter century experience.

Authors:  W H Edwards; S S Tapper; W H Edwards; J L Mulherin; R S Martin; J M Jenkins
Journal:  Ann Surg       Date:  1994-06       Impact factor: 12.969

8.  Results after balloon angioplasty or stenting of atherosclerotic subclavian artery obstruction.

Authors:  Sebastian Sixt; Aljoscha Rastan; Uwe Schwarzwälder; Karlheinz Bürgelin; Elias Noory; Thomas Schwarz; Ulrich Beschorner; Ulrich Frank; Christian Müller; Michael Hauk; Olli Leppanen; Kirsten Hauswald; Regina Brantner; Taher Nazary; Franz-Josef Neumann; Thomas Zeller
Journal:  Catheter Cardiovasc Interv       Date:  2009-02-15       Impact factor: 2.692

9.  Carotid-subclavian bypass: a twenty-two-year experience.

Authors:  M J Vitti; B W Thompson; R C Read; P J Gagne; G W Barone; R W Barnes; J F Eidt
Journal:  J Vasc Surg       Date:  1994-09       Impact factor: 4.268

Review 10.  Critical evaluation of axilloaxillary artery bypass for surgical management of symptomatic subclavian and innominate artery occlusive disease.

Authors:  R C Lowell; J L Mills
Journal:  Cardiovasc Surg       Date:  1993-10
View more
  2 in total

1.  Impact of Intravascular Ultrasound in Clinical Practice.

Authors:  Andres Vasquez; Neville Mistry; Jasvindar Singh
Journal:  Interv Cardiol       Date:  2014-08

2.  Significance of hemodynamic assessment by pressure wire for endovascular therapy of subclavian steal syndrome.

Authors:  Da-Wei Chen; Yu-Hai Gao; Jin Shi; Yan-Wei Yin; Wei-Qing Zhang
Journal:  Interv Neuroradiol       Date:  2020-01-22       Impact factor: 1.610

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.